Key result
Managing ventricular arrhythmias in HF requires a systematic multimodality approach combining OMT, ICDs, and ablation.
Why the study?
To provide an overview of current evidence regarding management strategies of ventricular arrhythmias in heart failure, with an emphasis on interventional treatment.
A multimodality approach including optimal medical therapy, ICDs, and catheter ablation is essential for managing ventricular arrhythmias in heart failure patients.
Multimodality care warrants consideration for ventricular arrhythmias in heart failure; leaves open optimal sequencing and comparative trials.
Congestive heart failure (HF) is a progressive affliction defined as the inability of the heart to sufficiently maintain blood flow. Ventricular arrhythmias (VAs) are common in patients with HF, and conversely, advanced HF promotes the risk of VAs. Management of VA in HF requires a systematic, multimodality approach that comprises optimization of medical therapy and use of implantable cardioverter-defibrillator and/or device combined with cardiac resynchronization therapy. Catheter ablation is one of the most important strategies with the potential to abolish or decrease the number of recurrences of VA in this population. It can be a curative strategy in arrhythmia-induced cardiomyopathy and may even save lives in cases of an electrical storm. Additionally, modulation of the autonomic nervous system and stereotactic radiotherapy have been introduced as novel methods to control refractory VAs. In patients with end-stage HF and refractory VAs, an institution of the mechanical circulatory support device and cardiac transplant may be considered. This review aims to provide an overview of current evidence regarding management strategies of VAs in HF with an emphasis on interventional treatment. Congestive heart failure (HF) is a progressive affliction defined as the inability of the heart to sufficiently maintain blood flow. Ventricular arrhythmias (VAs) are common in patients with HF, and conversely, advanced HF promotes the risk of VAs. Management of VA in HF requires a systematic, multimodality approach that comprises optimization of medical therapy and use of implantable cardioverter-defibrillator and/or device combined with cardiac resynchronization therapy. Catheter ablation is one of the most important strategies with the potential to abolish or decrease the number of recurrences of VA in this population. It can be a curative strategy in arrhythmia-induced cardiomyopathy and may even save lives in cases of an electrical storm. Additionally, modulation of the autonomic nervous system and stereotactic radiotherapy have been introduced as novel methods to control refractory VAs. In patients with end-stage HF and refractory VAs, an institution of the mechanical circulatory support device and cardiac transplant may be considered. This review aims to provide an overview of current evidence regarding management strategies of VAs in HF with an emphasis on interventional treatment. Key Findings▪Management of ventricular arrhythmias (VAs) in heart failure requires a systematic, multimodality approach.▪Besides optimal medical therapy, implantable cardioverter-defibrillators remain the key component for secondary and primary prevention of sudden cardiac death.▪In patients with recurrent VAs, catheter ablation effectively decreases arrhythmia burden and represents life-saving therapy in patients with electrical storm or incessant VAs.▪Novel therapeutic modalities are currently under evaluation to control otherwise refractory VAs. ▪Management of ventricular arrhythmias (VAs) in heart failure requires a systematic, multimodality approach.▪Besides optimal medical therapy, implantable cardioverter-defibrillators remain the key component for secondary and primary prevention of sudden cardiac death.▪In patients with recurrent VAs, catheter ablation effectively decreases arrhythmia burden and represents life-saving therapy in patients with electrical storm or incessant VAs.▪Novel therapeutic modalities are currently under evaluation to control otherwise refractory VAs.
No takes yet. Share an insight, caveat, or question.
Peichl et al. (2021) conducted a review in Ventricular arrhythmias in heart failure. Multimodality management (medical therapy, ICD, catheter ablation) was evaluated. Management of ventricular arrhythmias in heart failure requires a systematic, multimodality approach including optimal medical therapy, ICDs, and catheter ablation for recurrent cases.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: